A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients (Q60618634)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients |
article |
Statements
A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients (English)
Myrto Trakatelli
Michel Toungouz
Didier Blocklet
Ygierne Dodoo
Laurence Gordower
Marianne Laporte
Pierre Vereecken
Francois Sales
Laurent Mortier
Naima Mazouz
Micheline Lambermont
Pierre Coulie
Michel Goldman
Thierry Velu
Serge Goldman
20 August 2005